1-(2,6-DIFLUOROPHENYL)-3-(2-PIPERAZIN-1-YLETHYL)-1,3-DIHYDRO-2,1,3-BENZOTHIADIAZOLE 2,2-DIOXIDE MONOHYDROCHLORIDE
UNII HD7XVD6FH8
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-(2,6-difluorophenyl)-3-(2-piperazin-1-ylethyl)-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide Monohydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HD7XVD6FH8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1233485-19-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H20F2N4O2S.ClH WZYNILHOKGNAMR-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-(2,6-difluorophenyl)-3-(2-piperazin-1-ylethyl)-1,3-dihydro-2,1,3-benzothiadiazole 2,2-dioxide Monohydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.